In contrast, KRAS G12C mutations are detected in only 3–4% of all colorectal cancer (CRC) cases, representing approximately 6.4% of KRAS-mutated colorectal tumors [10,11]. This evidence concerns the gene KRAS and colorectal carcinoma.